Image

Visual and Postural Behavior in Myopic and Non-Myopic Teenagers

Visual and Postural Behavior in Myopic and Non-Myopic Teenagers

Recruiting
12-17 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn whether different types of eyeglasses prescription and different types of lenses change how close teenagers hold objects when looking at them up close. The study includes adolescents who are non-myopic and adolescents who are myopic and wear either single-vision lenses or lenses slowing down myopia progression.

The main questions it aims to answer are:

Do teenagers in these three groups use different average working distances (eye-to-object distance) during everyday tasks?

Does wearing Essilor® Stellest® lenses change working distance compared with wearing single-vision lenses?

Researchers will compare the three groups to see if their working distances differ.

Participants will:

Complete an initial optometric eye examination.

Come for a second visit where they perform everyday activities while wearing a motion-capture system that measures how they move and how far they hold objects.

Eligibility

Inclusion Criteria:

  • Volunteer adolescent, fluent in French, able to follow protocol and read and write
  • Aged between 12 and 17 years and 6 months
  • Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could interfere with visual or cognitive functions.
  • If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out during the previous year
  • If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study.
  • If the subject is nearsighted: -6.5D ≤ equivalent sphere ≤ -0.5D with usual correction
  • If the subject is not nearsighted: -0.5 \< equivalent sphere ≤ +2.5

Exclusion Criteria:

  • Age ≤ 12 years
  • Age \> 17 years and 6 months
  • Pregnant or breastfeeding women (Article L1121-5)
  • Persons (legal representatives or subjects) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8 and persons admitted to a health or social care facility for purposes other than research
  • Participants who are currently excluded from another study
  • All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code)
  • Declared neurological deficit, in particular a history of epileptic pathology or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders)
  • Severe declared eye disease involving loss of visual field, such as glaucoma, involving loss of acuity and severe discomfort in low-light or overly bright environments, such as retinitis pigmentosa, or declared and treated dry eye syndrome.
  • Gougerot-Sjögren syndrome or declared dry eye syndrome
  • Declared aphakia or pseudophakia (intraocular implant)
  • Declared systemic pathology, medical treatment, or medication with an effect on vision
  • People with declared muscle paralysis
  • Binocular vision problems such as amblyopia, strabismus, or nystagmus
  • Children of employees or employees of Essilor International, Luxottica, GrandVision, and their subsidiaries
  • Individuals who have undergone previous refractive surgery, have a history of strabismus surgery, or have a history of any type of eye surgery

Study details
    Teenagers
    Myopia

NCT07440134

Essilor International

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.